Title(s):
Professor of Pediatrics
Appointment Phone:
410-614-2359
Primary Location:
Johns Hopkins Pediatric Specialty Clinic
Expertise:
Pediatric Endocrinology
Education and Experience
Training
- University of Maryland School of Medicine (Baltimore MD)/ (1970)
Residencies
- The Johns Hopkins Hospital (Baltimore MD)/ Pedaitrics (1972)
Fellowships
- The Johns Hopkins Hospital (Baltimore MD)/ Pediatric Endocrinology (1974)
Certifications
- Pediatric Endocrinology, American Board of Pediatrics (1978)
- Pediatrics, American Board of Pediatrics (1975)
Locations
Johns Hopkins Pediatric Specialty Clinic
200 N. Wolfe Street
Rubenstein Child Health
Baltimore, MD 21287
Phone: 410-955-6463
Appointment Phone: 410-614-2359
Fax: 410-955-9773
Location Map
Department / Division
-
Pediatrics - Endocrinology
Centers/Institutes
Bio
Biography
After training, Dr. Plotnick joined the faculty of the Department of Pediatrics at Hopkins in the division of Pediatric Endocrinology. She became a full professor in 2000. She has served as clinical director of the division for many years, and as interim division director twice.
Her major clinical interests are in type 1 diabetes and growth. She has authored and co-authored many papers and chapters on these and other pediatric endocrine topics. She was chosen to be one of a few pediatric diabetes specialists to write pediatric standards of care for the American Diabetes Association. She has participated in numerous clinical trials over the last 3 decades primarily in the areas of growth and growth hormone. Deeply devoted to patients and families, she and her colleagues and nurses have organized, and manage and operate a highly sought-after and ever-expanding clinical program.
Dr. Plotnick has served on many department, university and hospital committees throughout her Hopkins career, and has chaired several. Since 2000, she has organized and managed a successful CME course with the goal of teaching pediatric endocrinology to primary care providers.
Her major clinical interests are in type 1 diabetes and growth. She has authored and co-authored many papers and chapters on these and other pediatric endocrine topics. She was chosen to be one of a few pediatric diabetes specialists to write pediatric standards of care for the American Diabetes Association. She has participated in numerous clinical trials over the last 3 decades primarily in the areas of growth and growth hormone. Deeply devoted to patients and families, she and her colleagues and nurses have organized, and manage and operate a highly sought-after and ever-expanding clinical program.
Dr. Plotnick has served on many department, university and hospital committees throughout her Hopkins career, and has chaired several. Since 2000, she has organized and managed a successful CME course with the goal of teaching pediatric endocrinology to primary care providers.
Expertise
- Pediatric Endocrinology
Research
Research and Publications
from 2000 forward:
Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL, Dannies PS. Autosomal dominant growth hormone (GH) deficiency type II:the Del32-7 GH deletion mutant suppresses secretion of wild-type GH. Endocrinology. 2000 Mar; 141(3):883-90.
Salvatori R, Fan X, Phillips III JA, Espigares-Martin R, Martin de Lara I, Freeman KL, Plotnick L, Al-Ashwal A and Levine MA. Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type Ib. J Clin Endocrinol Metab. 2001 Jan;86(1)273-9.
Plotnick LP. Insulin Pumps in Pediatrics. The Endocrinologist, 2001.
Wisniewski AB, Migeon CJ, Gearhart JP, Rock JA, Berkovitz GD, Plotnick LP, Meyer-Bahlburg HF, Money J. Congenital micropenis: long-term medical, surgical and psychosocial follow-up of individuals raised male or female. Horm. Res. 2001;56(1-2):3-11.
Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes.
Diabetes Care. 2003 Apr;26(4):1142-6.
Plotnick LP. The next step in blood glucose monitoring?
Pediatrics. 2003 Apr;111(4 Pt 1):885.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005 Jan;28(1):186-212.
Iannotti RJ, Schneider S, Nansel TR, Haynie DL, Plotnick LP, Clark LM, Sobel DO, Simons-Morton B. Self-efficacy, outcome expectations, and diabetes self-management in adolescents with type 1 diabetes. Dev Behav Pediatr. 2006 Apr;27(2):98-105.
Iannotti RJ, Nansel TR, Schneider S, Haynie DL, Simons-Morton B, Sobel DO, Zeitzoff L, Plotnick LP, Clark L. Assessing regimen adherence of adolescents with type 1 diabetes. Diabetes Care. 2006 Oct;29(10):2263-7.
Schneider S, Iannotti RJ, Nansel TR, Haynie DL, Simons-Morton B, Sobel DO, Zeitzoff L, Clark L, Plotnick LP. Identification of distinct self-management styles of adolescents with type 1 diabetes. Diabetes Care. 2007 May;30(5):1107-12.
Nansel TR, Iannotti RJ, Simons-Morton BG, Cox C, Plotnick LP, Clark LM, Zeitzoff L. Diabetes personal trainer outcomes: short-term and 1-year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes. Diabetes Care. 2007 Oct;30(10):2471-7.
Cooke DW, Plotnick L. Management of Diabetic Ketoacidosis in Children and Adolescents. Pediatr. Rev. 2008 Dec; 29(12):431-436.
Cooke DW, Plotnick L. Type 1 Diabetes Mellitus in Pediatrics. Pediatr. Rev. 2008 Nov;29(11):374-385.
Rapaport R, Saenger P, Wajnrach MP; Pfizer SGA collaborative Study Group (includes Plotnick, L). Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States. J Pediatr Endocrinol Metab. 2008 May;21(5): 411-422.
Plotnick L, Rapaport R, Desrosiers P, Fuqua JS, Update from the GHMonitorSM Observational Registry in Children Treated with Recombinant Human Growth Hormone (Saizen), Pediatr Endocrinol Rev. 2009 Jan;6 Suppl 2:278-82.
Nansel TR, Iannotti RJ, Simons-Morton, BG, Plotnick LP, Clark, LM, Zeitzoff, L.
Long-Term Maintenance of Treatment Outcomes: Diabetes Personal Trainer Intervention for Youth with Type 1 Diabetes. Diabetes Care, 2009 May;32(5):807-9.
Mohamadi A, Lipkin P, ... Clark L, Plotnick L, Extending the age of KCNJ11 mutations. a)in press, 2009. Pediatric Diabetes. b) Poster presentation at PAS meeting 5/3/09.
CHAPTERS
Plotnick LP, Cooke DW. Diabetes in Children. Conn''s Current Therapy, 2001.
Plotnick LP. Precocious Puberty In Pediatric and Adolescent Gynecology. Carpenter and Rock Eds. Lippincott, Williams & Wilkins, 161-164, 2000.
Libber SM and Plotnick LP. Polyuria. In Primary Pediatric Care, ed. 4. Hoekelman, ed. Mosby, 1214-1217, 2001.
Plotnick LP and Kritzler RK. Puberty: Normal and Abnormal. In Primary Pediatric Care, Hoekelman, ed. 4 Mosby, 1223-1226, 2001.
Miller RS, Libber SL, Plotnick LP. Polyuria. in AAP Textbook of Pediatric Care, McInerny, Adam, Campbell, Kamat and Kelleher, 2009; 1670-1675.
Long, DN, Kritzler RK, Plotnick LP. Puberty: Normal and Abnormal. in AAP Textbook of Pediatric Care, McInerny, ADam, Campbell, Kamat and Kelleher, 2009; 1683-1688.
Cooke DW, Plotnick L. Type 1 Diabetes in Kappy, Geffner, and Allen, Pediatric Endocrinology, in press, 2009.
Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL, Dannies PS. Autosomal dominant growth hormone (GH) deficiency type II:the Del32-7 GH deletion mutant suppresses secretion of wild-type GH. Endocrinology. 2000 Mar; 141(3):883-90.
Salvatori R, Fan X, Phillips III JA, Espigares-Martin R, Martin de Lara I, Freeman KL, Plotnick L, Al-Ashwal A and Levine MA. Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type Ib. J Clin Endocrinol Metab. 2001 Jan;86(1)273-9.
Plotnick LP. Insulin Pumps in Pediatrics. The Endocrinologist, 2001.
Wisniewski AB, Migeon CJ, Gearhart JP, Rock JA, Berkovitz GD, Plotnick LP, Meyer-Bahlburg HF, Money J. Congenital micropenis: long-term medical, surgical and psychosocial follow-up of individuals raised male or female. Horm. Res. 2001;56(1-2):3-11.
Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes.
Diabetes Care. 2003 Apr;26(4):1142-6.
Plotnick LP. The next step in blood glucose monitoring?
Pediatrics. 2003 Apr;111(4 Pt 1):885.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005 Jan;28(1):186-212.
Iannotti RJ, Schneider S, Nansel TR, Haynie DL, Plotnick LP, Clark LM, Sobel DO, Simons-Morton B. Self-efficacy, outcome expectations, and diabetes self-management in adolescents with type 1 diabetes. Dev Behav Pediatr. 2006 Apr;27(2):98-105.
Iannotti RJ, Nansel TR, Schneider S, Haynie DL, Simons-Morton B, Sobel DO, Zeitzoff L, Plotnick LP, Clark L. Assessing regimen adherence of adolescents with type 1 diabetes. Diabetes Care. 2006 Oct;29(10):2263-7.
Schneider S, Iannotti RJ, Nansel TR, Haynie DL, Simons-Morton B, Sobel DO, Zeitzoff L, Clark L, Plotnick LP. Identification of distinct self-management styles of adolescents with type 1 diabetes. Diabetes Care. 2007 May;30(5):1107-12.
Nansel TR, Iannotti RJ, Simons-Morton BG, Cox C, Plotnick LP, Clark LM, Zeitzoff L. Diabetes personal trainer outcomes: short-term and 1-year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes. Diabetes Care. 2007 Oct;30(10):2471-7.
Cooke DW, Plotnick L. Management of Diabetic Ketoacidosis in Children and Adolescents. Pediatr. Rev. 2008 Dec; 29(12):431-436.
Cooke DW, Plotnick L. Type 1 Diabetes Mellitus in Pediatrics. Pediatr. Rev. 2008 Nov;29(11):374-385.
Rapaport R, Saenger P, Wajnrach MP; Pfizer SGA collaborative Study Group (includes Plotnick, L). Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States. J Pediatr Endocrinol Metab. 2008 May;21(5): 411-422.
Plotnick L, Rapaport R, Desrosiers P, Fuqua JS, Update from the GHMonitorSM Observational Registry in Children Treated with Recombinant Human Growth Hormone (Saizen), Pediatr Endocrinol Rev. 2009 Jan;6 Suppl 2:278-82.
Nansel TR, Iannotti RJ, Simons-Morton, BG, Plotnick LP, Clark, LM, Zeitzoff, L.
Long-Term Maintenance of Treatment Outcomes: Diabetes Personal Trainer Intervention for Youth with Type 1 Diabetes. Diabetes Care, 2009 May;32(5):807-9.
Mohamadi A, Lipkin P, ... Clark L, Plotnick L, Extending the age of KCNJ11 mutations. a)in press, 2009. Pediatric Diabetes. b) Poster presentation at PAS meeting 5/3/09.
CHAPTERS
Plotnick LP, Cooke DW. Diabetes in Children. Conn''s Current Therapy, 2001.
Plotnick LP. Precocious Puberty In Pediatric and Adolescent Gynecology. Carpenter and Rock Eds. Lippincott, Williams & Wilkins, 161-164, 2000.
Libber SM and Plotnick LP. Polyuria. In Primary Pediatric Care, ed. 4. Hoekelman, ed. Mosby, 1214-1217, 2001.
Plotnick LP and Kritzler RK. Puberty: Normal and Abnormal. In Primary Pediatric Care, Hoekelman, ed. 4 Mosby, 1223-1226, 2001.
Miller RS, Libber SL, Plotnick LP. Polyuria. in AAP Textbook of Pediatric Care, McInerny, Adam, Campbell, Kamat and Kelleher, 2009; 1670-1675.
Long, DN, Kritzler RK, Plotnick LP. Puberty: Normal and Abnormal. in AAP Textbook of Pediatric Care, McInerny, ADam, Campbell, Kamat and Kelleher, 2009; 1683-1688.
Cooke DW, Plotnick L. Type 1 Diabetes in Kappy, Geffner, and Allen, Pediatric Endocrinology, in press, 2009.
Research Interests
- Type 1 diabetes. Growth disorders.
More Info
Languages
- English
Memberships
LWPES
ADA
Endocrine Society
AACE
ADA
Endocrine Society
AACE
Clinical Trials
- Type 1 diabetes. Growth Disorders.
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts